Areas of Focus
- Stem cell clinical therapy development
- G protein-coupled receptor signaling pathways
- Drug development for osteoporosis, arthritis, intervertebral disc degeneration, and bone tumors
Work Experience
- 2010 - Present: Reviewer for international journals such as Cancer Res, Mol Oncol, Curr Mol Med
- 2017 - Present: Vice Director, East China Normal University-Shanghai Changzheng Hospital Bone Tumor Joint Research Center
Academic Background & Achievements
- PhD in Cell Biochemistry, Chinese Academy of Sciences
- National Outstanding Youth, Ministry of Education High-level Young Talent
Publications
- RSPO2/RANKL-LGR4 signaling regulates osteoclastic pre-metastatic niche formation and bone metastasis, Luo J et al., 2022
- PGE2 Activates EP4 in Subchondral Bone Osteoclasts to Regulate Osteoarthritis, Luo J et al., 2022
Awards
- 2017: First Prize, Basic Research in Orthopedics, Chinese Medical Association
- 2017: First Prize, Shanghai Science and Technology Progress Award
